PlainRecalls
FDA Drug Low Class III Terminated

Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA

Reported: November 3, 2021 Initiated: October 18, 2021 #D-0078-2022

Product Description

Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA

Reason for Recall

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Details

Recalling Firm
MACLEODS PHARMA USA, INC
Units Affected
135,082 Blister Packs/2,431,476 tablets
Distribution
Nationwide within the United States
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA. Recalled by MACLEODS PHARMA USA, INC. Units affected: 135,082 Blister Packs/2,431,476 tablets.
Why was this product recalled?
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 3, 2021. Severity: Low. Recall number: D-0078-2022.